Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Exchange Rate Effect (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Exchange Rate Effect data on record, last reported at -$122000.0 in Q3 2025.

  • For Q3 2025, Exchange Rate Effect fell 131.77% year-over-year to -$122000.0; the TTM value through Sep 2025 reached $48000.0, down 89.74%, while the annual FY2024 figure was -$677000.0, 299.71% down from the prior year.
  • Exchange Rate Effect reached -$122000.0 in Q3 2025 per UTMD's latest filing, down from $520000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $819000.0 in Q4 2022 and bottomed at -$949000.0 in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$40105.3, with a median of -$11000.0 recorded in 2021.
  • The widest YoY moves for Exchange Rate Effect: up 7545.45% in 2022, down 2541.38% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at -$11000.0 in 2021, then skyrocketed by 7545.45% to $819000.0 in 2022, then plummeted by 40.42% to $488000.0 in 2023, then plummeted by 234.63% to -$657000.0 in 2024, then skyrocketed by 81.43% to -$122000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$122000.0 in Q3 2025, $520000.0 in Q2 2025, and $307000.0 in Q1 2025.